Narrow search
Showing 1 - 10 of 191
Cover Image
Pharmaceutical Prices : The Impact of the Launch Strategy - An Analysis of German Data
Böhler, Yvonne-Beatrice - 2019
This paper reports the results from a statistical analysis of pharmaceutical price negotiations in Germany, where the … pricing system was changed in 2011 in order to tie prices more to the benefits of the pharmaceuticals. A multiple linear … regression of 187 pharmaceuticals which were assessed from 2011 to 2017 suggests that, despite the change, the manufacturers …
Persistent link: https://www.econbiz.de/10012860771
Cover Image
The Effect of Bargaining Power Determinants on Pharmaceutical Prices
Linde, Sebastian - 2020
explains large price heterogeneities across buyers, drug classes, and time periods. Additionally, of the drug price variation … transaction volume, buyer's loyalty, and multiple drug purchases strengthens buyer's bargaining power and results in a drug price …
Persistent link: https://www.econbiz.de/10012845687
Cover Image
The Impact of New Drug Launches on Hospitalization in 2015 for 67 Medical Conditions in 15 OECD Countries : A Two-Way Fixed-Effects Analysis
Lichtenberg, Frank R. - 2019
There are two types of prescription drug cost offsets. The first type of cost offset—from prescription drug use—is primarily about the effect of changes in drug quantity (e.g. due to changes in out-of-pocket drug costs) on other medical costs. The second type of cost offset—the cost offset...
Persistent link: https://www.econbiz.de/10012889758
Cover Image
Dynamic Mergers Effects on R&D Investments and Drug Development Across Research Phases in the Pharmaceutical Industry
Siebert, Ralph - 2020
Pharmaceutical firms spend increasing amounts in mergers and acquisitions (M&As), which raises the question of whether sufficient investment is left after mergers to further develop firms' internal drug development capability. We evaluate the effects of M&As on firms' post-merger R&D investments...
Persistent link: https://www.econbiz.de/10012833741
Cover Image
Pricing the Pharmaceuticals When the Ability to Pay Differs : Taking Vertical Equity Seriously
Kanniainen, Vesa - 2020
, the paper analyzes the public insurance of the pharmaceutical products in terms of price controls and the socially optimal … third-degree price discrimination. It characterizes first the Ramsey pricing rule in the absence of insurance and in the … case where the producer price has to cover the R&D sunk cost of the firm. Subsequently, conditions for a welfare increasing …
Persistent link: https://www.econbiz.de/10012843430
Cover Image
The Patent Buyout Price for Human Papilloma Virus (HPV) Vaccine and the Ratio of R&D Costs to the Patent Value
Songane, Mario - 2020
HPV vaccination rates while keeping innovation incentives. We estimate the global patent buyout price as the present … Merck with extraordinarily strong price setting power …
Persistent link: https://www.econbiz.de/10012825394
Cover Image
Vaccination Lottery
Kim, Duk Gyoo - 2021
Ohio announced a Vax-a-Million Lottery in May 2021 to encourage people vaccinated. If people may avoid vaccination because (1) they worry about rare but critical side effects or (2) they want to free ride on herd immunity, the vaccination lottery may work better or worse than a lump-sum transfer...
Persistent link: https://www.econbiz.de/10013216770
Cover Image
Physician Effects in Antibiotic Prescribing : Evidence from Physician Exits
Huang, Shan; Ullrich, Hannes - 2021
Human antibiotic consumption is considered the main driver of antibiotic resistance. Reducing human antibiotic consumption without compromising health care quality poses one of the most important global health policy challenges. A crucial condition for designing effective policies is to identify...
Persistent link: https://www.econbiz.de/10013218285
Cover Image
Drivers of COVID-19 Vaccinations : Vaccine Administration and Delivery Efficiency in the United States
Goel, Rajeev K.; Nelson, Michael A. - 2021
This paper adds some formal research to the success of ongoing efforts to combat the COVID-19 pandemic by examining the drivers of the administration and delivery efficiency of coronavirus vaccines. For this purpose, we use data from the 50 US states and place the formal analysis in the context...
Persistent link: https://www.econbiz.de/10013235098
Cover Image
How Does the Vaccine Approval Procedure Affect COVID-19 Vaccination Intentions?
Angerer, Silvia; Glätzle-Rützle, Daniela; … - 2022
Peoples’ willingness to vaccinate is critical to combating the COVID-19 pandemic. We devise a representative experiment to study how the design of the vaccine approval procedure affects public attitudes towards vaccination. Compared to an Emergency Use Authorization, choosing the more thorough...
Persistent link: https://www.econbiz.de/10013292647